Omacetaxine for Consolidation and Maintenance in Patients Age ≥ 55 With AML in First Remission: A Pilot Study
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Omacetaxine mepesuccinate (Primary) ; Anthracyclines; Cytarabine
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 05 Sep 2019 Status changed from completed to discontinued.
- 30 Aug 2018 Status changed from recruiting to completed.
- 06 Apr 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.